{
  "doctors": [
    {
      "id": "doctor-1",
      "name": "Dr. Sarah Smith",
      "specialty": "Cardiology",
      "email": "sarah.smith@hospital.com",
      "phone": "+1 (555) 123-4567",
      "sessions": 2,
      "avgEngagement": 99,
      "totalTime": "0h 1m",
      "status": "active",
      "lastSession": "2025-06-17T04:36:03.080Z"
    },
    {
      "id": "doctor-2",
      "name": "Dr. Michael Johnson",
      "specialty": "Endocrinology",
      "email": "m.johnson@clinic.com",
      "phone": "+1 (555) 234-5678",
      "sessions": 0,
      "avgEngagement": 0,
      "totalTime": "0h 0m",
      "status": "active"
    }
  ],
  "presentations": [
    {
      "id": "presentation-1",
      "title": "Cardiomax Treatment Protocol",
      "description": "New cardiovascular medication protocol for hypertension patients",
      "slides": 6,
      "sessions": 2,
      "avgEngagement": 99,
      "status": "active",
      "createdAt": "2025-06-17T03:54:24.962Z",
      "lastUsed": "2025-06-17T04:36:03.080Z"
    },
    {
      "id": "presentation-2",
      "title": "Glucobalance Therapy",
      "description": "Latest diabetes management medication and treatment guidelines",
      "slides": 6,
      "sessions": 0,
      "avgEngagement": 0,
      "status": "active",
      "createdAt": "2025-06-17T03:54:24.962Z"
    }
  ],
  "slides": [
    {
      "id": "slide-1-0",
      "presentationId": "presentation-1",
      "title": "Slide 1: Cardiomax Overview",
      "content": "Cardiomax is a next-generation ACE inhibitor for hypertension management",
      "imageUrl": "/slides/title.png",
      "order": 0
    },
    {
      "id": "slide-1-1",
      "presentationId": "presentation-1",
      "title": "Slide 2: Clinical Indications",
      "content": "Primary indications include hypertension, heart failure, and post-MI treatment",
      "imageUrl": "/slides/agenda.png",
      "order": 1
    },
    {
      "id": "slide-1-2",
      "presentationId": "presentation-1",
      "title": "Slide 3: Mechanism of Action",
      "content": "Selectively blocks angiotensin II receptors with higher binding affinity",
      "imageUrl": "/slides/about-us.png",
      "order": 2
    },
    {
      "id": "slide-1-3",
      "presentationId": "presentation-1",
      "title": "Slide 4: Dosage Guidelines",
      "content": "Starting dose: 5mg daily, may increase to 10mg after 2 weeks",
      "imageUrl": "/slides/product-overview.png",
      "order": 3
    },
    {
      "id": "slide-1-4",
      "presentationId": "presentation-1",
      "title": "Slide 5: Side Effects Profile",
      "content": "Common side effects include dry cough (3%), dizziness (2%), and headache (1%)",
      "imageUrl": "/slides/product-benefits.png",
      "order": 4
    },
    {
      "id": "slide-1-5",
      "presentationId": "presentation-1",
      "title": "Slide 6: Patient Outcomes",
      "content": "Clinical trials show 24% reduction in cardiovascular events over 5 years",
      "imageUrl": "/slides/market-overview.png",
      "order": 5
    },
    {
      "id": "slide-2-0",
      "presentationId": "presentation-2",
      "title": "Slide 1: Glucobalance Introduction",
      "content": "Glucobalance is a dual SGLT2/GLP-1 inhibitor for type 2 diabetes",
      "imageUrl": "/placeholder.svg?height=600&width=800&text=Glucobalance+Title",
      "order": 0
    },
    {
      "id": "slide-2-1",
      "presentationId": "presentation-2",
      "title": "Slide 2: Treatment Indications",
      "content": "Indicated for adults with T2DM with inadequate control on metformin",
      "imageUrl": "/placeholder.svg?height=600&width=800&text=Treatment+Agenda",
      "order": 1
    },
    {
      "id": "slide-2-2",
      "presentationId": "presentation-2",
      "title": "Slide 3: Pharmacodynamics",
      "content": "Increases glucose excretion and improves insulin sensitivity",
      "imageUrl": "/placeholder.svg?height=600&width=800&text=Company+Profile",
      "order": 2
    },
    {
      "id": "slide-2-3",
      "presentationId": "presentation-2",
      "title": "Slide 4: Administration Protocol",
      "content": "Once-daily oral tablet, 25mg with or without food",
      "imageUrl": "/placeholder.svg?height=600&width=800&text=Drug+Mechanism",
      "order": 3
    },
    {
      "id": "slide-2-4",
      "presentationId": "presentation-2",
      "title": "Slide 5: Adverse Reactions",
      "content": "Monitor for hypoglycemia (2%), UTIs (4%), and dehydration (1%)",
      "imageUrl": "/placeholder.svg?height=600&width=800&text=Clinical+Benefits",
      "order": 4
    },
    {
      "id": "slide-2-5",
      "presentationId": "presentation-2",
      "title": "Slide 6: Clinical Efficacy Data",
      "content": "HbA1c reduction of 1.8% at 6 months compared to 0.9% with standard therapy",
      "imageUrl": "/placeholder.svg?height=600&width=800&text=Market+Analysis",
      "order": 5
    }
  ],
  "sessions": [
    {
      "id": "732e3c44-4f8c-4d1a-b326-856d8bb29b62",
      "doctorId": "doctor-1",
      "presentationId": "presentation-1",
      "startTime": "2025-06-17T03:54:24.963Z",
      "endTime": "2025-06-17T03:54:49.293Z",
      "totalTime": 24.33,
      "avgEngagement": 99
    },
    {
      "id": "6cea2bc9-7c73-4179-b859-41500fdea301",
      "doctorId": "doctor-1",
      "presentationId": "presentation-1",
      "startTime": "2025-06-17T04:35:46.740Z",
      "endTime": "2025-06-17T04:36:03.080Z",
      "totalTime": 16.34,
      "avgEngagement": 98
    }
  ],
  "slideAnalytics": [
    {
      "sessionId": "732e3c44-4f8c-4d1a-b326-856d8bb29b62",
      "slideId": "slide-1-0",
      "timeSpent": 2746,
      "id": "c024ec81-856f-43f2-a716-42e83cb01cb4"
    },
    {
      "sessionId": "732e3c44-4f8c-4d1a-b326-856d8bb29b62",
      "slideId": "slide-1-1",
      "timeSpent": 4298,
      "id": "66c97f9e-7286-48c1-adaf-85216645a620"
    },
    {
      "sessionId": "732e3c44-4f8c-4d1a-b326-856d8bb29b62",
      "slideId": "slide-1-2",
      "timeSpent": 4962,
      "id": "834d75e1-f77c-4215-b643-89a6972159c5"
    },
    {
      "sessionId": "732e3c44-4f8c-4d1a-b326-856d8bb29b62",
      "slideId": "slide-1-3",
      "timeSpent": 5534,
      "id": "0758a55e-a6e9-44e0-8ee4-353ac24c78a5"
    },
    {
      "sessionId": "732e3c44-4f8c-4d1a-b326-856d8bb29b62",
      "slideId": "slide-1-4",
      "timeSpent": 2589,
      "id": "a475ab4d-768a-446b-ad25-2bee50ccd332"
    },
    {
      "sessionId": "732e3c44-4f8c-4d1a-b326-856d8bb29b62",
      "slideId": "slide-1-5",
      "timeSpent": 3974,
      "id": "e8d25f95-21b7-4988-9fdb-c5641c93dc25"
    },
    {
      "sessionId": "6cea2bc9-7c73-4179-b859-41500fdea301",
      "slideId": "slide-1-0",
      "timeSpent": 1774,
      "id": "5581ac1e-5ac0-4dad-8258-e5c36688e98d"
    },
    {
      "sessionId": "6cea2bc9-7c73-4179-b859-41500fdea301",
      "slideId": "slide-1-1",
      "timeSpent": 2601,
      "id": "729649fa-8396-4160-b840-f7a71a704bfb"
    },
    {
      "sessionId": "6cea2bc9-7c73-4179-b859-41500fdea301",
      "slideId": "slide-1-2",
      "timeSpent": 3950,
      "id": "1b8bb11e-5104-4925-b281-882293bf1d71"
    },
    {
      "sessionId": "6cea2bc9-7c73-4179-b859-41500fdea301",
      "slideId": "slide-1-3",
      "timeSpent": 5027,
      "id": "1dab4ef9-df28-47a7-b4bd-cb7f05f54418"
    },
    {
      "sessionId": "6cea2bc9-7c73-4179-b859-41500fdea301",
      "slideId": "slide-1-4",
      "timeSpent": 968,
      "id": "71c00f56-8bc3-46fd-b1f2-93d9f6ad9d9c"
    },
    {
      "sessionId": "6cea2bc9-7c73-4179-b859-41500fdea301",
      "slideId": "slide-1-5",
      "timeSpent": 1747,
      "id": "ae1fbcdc-9db1-4c50-adbf-1e4ca0203ff0"
    }
  ]
}